Gene Symbol | Gene ID | Gene Info |
---|---|---|
Plagl1
|
ENSMUSG00000019817.12 | pleiomorphic adenoma gene-like 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_13107920_13108404 | Plagl1 | 5303 | 0.228687 | 0.65 | 8.6e-08 | Click! |
chr10_13108416_13108609 | Plagl1 | 4953 | 0.232446 | 0.62 | 4.6e-07 | Click! |
chr10_13061226_13061377 | Plagl1 | 797 | 0.637143 | 0.62 | 5.5e-07 | Click! |
chr10_13060986_13061146 | Plagl1 | 562 | 0.761716 | 0.60 | 1.3e-06 | Click! |
chr10_13115061_13115467 | Plagl1 | 1100 | 0.543375 | 0.59 | 1.9e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_66240081_66240411 | 20.43 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
45805 |
0.14 |
chr10_81559146_81561402 | 19.37 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr4_22488420_22489023 | 16.18 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
355 |
0.83 |
chr1_5019296_5020184 | 13.92 |
Rgs20 |
regulator of G-protein signaling 20 |
201 |
0.93 |
chr6_127404014_127404362 | 12.59 |
Gm34091 |
predicted gene, 34091 |
6942 |
0.17 |
chr13_59092007_59092498 | 11.73 |
4930415C11Rik |
RIKEN cDNA 4930415C11 gene |
8159 |
0.17 |
chr12_3236518_3237725 | 11.04 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr13_39524261_39524439 | 10.76 |
Gm47351 |
predicted gene, 47351 |
8753 |
0.2 |
chr11_3132475_3133419 | 10.10 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
3060 |
0.17 |
chr5_27873156_27873523 | 9.98 |
Gm5551 |
predicted gene 5551 |
12890 |
0.15 |
chr16_43503682_43504014 | 9.90 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
151 |
0.97 |
chr8_123411336_123412017 | 9.62 |
Tubb3 |
tubulin, beta 3 class III |
86 |
0.91 |
chr1_22806069_22806442 | 9.53 |
Rims1 |
regulating synaptic membrane exocytosis 1 |
261 |
0.95 |
chr6_134888153_134888812 | 9.41 |
Gpr19 |
G protein-coupled receptor 19 |
650 |
0.56 |
chr11_71439882_71440106 | 9.35 |
Gm16013 |
predicted gene 16013 |
3814 |
0.28 |
chr7_79578006_79578675 | 9.17 |
Gm45168 |
predicted gene 45168 |
728 |
0.49 |
chr8_90741015_90741332 | 8.89 |
Gm35850 |
predicted gene, 35850 |
398 |
0.82 |
chr18_25657085_25657320 | 8.85 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
56568 |
0.13 |
chr7_79592943_79593212 | 8.76 |
Gm45169 |
predicted gene 45169 |
464 |
0.65 |
chr6_103513092_103513465 | 8.70 |
Chl1 |
cell adhesion molecule L1-like |
1948 |
0.31 |
chr18_81924709_81924903 | 8.70 |
Gm50292 |
predicted gene, 50292 |
8078 |
0.17 |
chr14_12338554_12338736 | 8.53 |
Gm24578 |
predicted gene, 24578 |
4741 |
0.14 |
chr8_64691836_64692235 | 8.52 |
Cpe |
carboxypeptidase E |
1019 |
0.52 |
chr16_94473045_94473706 | 8.13 |
Ttc3 |
tetratricopeptide repeat domain 3 |
6853 |
0.16 |
chr2_158616303_158616596 | 7.90 |
Gm14205 |
predicted gene 14205 |
4629 |
0.13 |
chr8_48204156_48204432 | 7.89 |
Gm32842 |
predicted gene, 32842 |
66691 |
0.11 |
chr12_29547825_29548188 | 7.89 |
Myt1l |
myelin transcription factor 1-like |
12784 |
0.23 |
chr3_88205532_88206477 | 7.84 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr4_151139945_151140096 | 7.74 |
Camta1 |
calmodulin binding transcription activator 1 |
436 |
0.86 |
chr3_119361627_119361843 | 7.71 |
Gm23432 |
predicted gene, 23432 |
277139 |
0.01 |
chr7_57591534_57591735 | 7.70 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
104 |
0.97 |
chrX_100767870_100768490 | 7.69 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
185 |
0.93 |
chr6_54553141_54553306 | 7.67 |
Scrn1 |
secernin 1 |
1223 |
0.45 |
chr17_52602043_52602770 | 7.62 |
Gm27217 |
predicted gene 27217 |
254 |
0.55 |
chrX_9662400_9663303 | 7.50 |
Dynlt3 |
dynein light chain Tctex-type 3 |
152 |
0.97 |
chr7_141468254_141469266 | 7.46 |
Cd151 |
CD151 antigen |
62 |
0.89 |
chr2_51088193_51088355 | 7.43 |
Rnd3 |
Rho family GTPase 3 |
60820 |
0.14 |
chr2_114012698_114013215 | 7.38 |
A530058N18Rik |
RIKEN cDNA A530058N18 gene |
607 |
0.46 |
chr7_51748719_51749329 | 7.36 |
Gm7336 |
predicted gene 7336 |
2377 |
0.28 |
chr11_57553039_57553347 | 7.26 |
Gm12243 |
predicted gene 12243 |
19319 |
0.16 |
chr5_137734700_137735086 | 7.25 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
4825 |
0.1 |
chr10_81399861_81400154 | 7.21 |
Nfic |
nuclear factor I/C |
547 |
0.46 |
chr18_43687278_43687971 | 7.15 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
1 |
0.98 |
chr18_89768868_89769818 | 7.08 |
Dok6 |
docking protein 6 |
185 |
0.96 |
chr1_18058368_18058994 | 7.08 |
Gm28756 |
predicted gene 28756 |
109 |
0.82 |
chr17_91093116_91093291 | 7.06 |
Nrxn1 |
neurexin I |
132 |
0.95 |
chr1_118321665_118322443 | 7.06 |
Nifk |
nucleolar protein interacting with the FHA domain of MKI67 |
98 |
0.96 |
chr10_26695678_26695829 | 7.05 |
Gm48893 |
predicted gene, 48893 |
179 |
0.94 |
chr7_141070009_141070863 | 7.03 |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
161 |
0.88 |
chr7_44310178_44311500 | 7.01 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chr18_43390705_43391091 | 6.96 |
Dpysl3 |
dihydropyrimidinase-like 3 |
2479 |
0.33 |
chr11_94158421_94158910 | 6.93 |
B230206L02Rik |
RIKEN cDNA B230206L02 gene |
23005 |
0.17 |
chr18_32377441_32378197 | 6.93 |
A830052D11Rik |
RIKEN cDNA A830052D11 gene |
4 |
0.92 |
chr9_103504895_103505451 | 6.89 |
Tmem108 |
transmembrane protein 108 |
11562 |
0.11 |
chr19_6499050_6499464 | 6.88 |
Nrxn2 |
neurexin II |
1422 |
0.29 |
chr2_113757551_113758181 | 6.86 |
Grem1 |
gremlin 1, DAN family BMP antagonist |
780 |
0.67 |
chr2_33593309_33593623 | 6.80 |
Gm38011 |
predicted gene, 38011 |
20932 |
0.15 |
chr6_51849053_51849306 | 6.74 |
Skap2 |
src family associated phosphoprotein 2 |
22750 |
0.22 |
chr14_22679461_22679651 | 6.71 |
Lrmda |
leucine rich melanocyte differentiation associated |
83043 |
0.09 |
chr4_22479124_22479682 | 6.58 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
8963 |
0.17 |
chr2_38424274_38424495 | 6.57 |
Gm13589 |
predicted gene 13589 |
382 |
0.83 |
chr10_89257021_89257224 | 6.56 |
Ano4 |
anoctamin 4 |
14 |
0.99 |
chr17_66479155_66479309 | 6.54 |
Rab12 |
RAB12, member RAS oncogene family |
21087 |
0.14 |
chr7_44593726_44594565 | 6.52 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
150 |
0.87 |
chr16_44530838_44531222 | 6.50 |
Mir3081 |
microRNA 3081 |
27099 |
0.17 |
chr9_110249742_110250130 | 6.48 |
Cspg5 |
chondroitin sulfate proteoglycan 5 |
3871 |
0.14 |
chr1_56726194_56726492 | 6.47 |
Hsfy2 |
heat shock transcription factor, Y-linked 2 |
88908 |
0.09 |
chr17_58932764_58933222 | 6.43 |
Pdzph1 |
PDZ and pleckstrin homology domains 1 |
39498 |
0.16 |
chr7_90886426_90886732 | 6.42 |
Gm45159 |
predicted gene 45159 |
493 |
0.68 |
chr15_69923116_69923267 | 6.42 |
Gm19782 |
predicted gene, 19782 |
88432 |
0.1 |
chr14_93380941_93381092 | 6.40 |
Gm48964 |
predicted gene, 48964 |
69879 |
0.13 |
chr3_130962179_130962620 | 6.38 |
2010110G14Rik |
RIKEN cDNA 2010110G14 gene |
25062 |
0.12 |
chr2_127667114_127667319 | 6.38 |
Gm22889 |
predicted gene, 22889 |
10454 |
0.12 |
chr3_34679908_34680220 | 6.36 |
Gm43206 |
predicted gene 43206 |
2569 |
0.18 |
chr13_84571624_84571828 | 6.35 |
Gm26913 |
predicted gene, 26913 |
119215 |
0.06 |
chr9_20703833_20704274 | 6.33 |
Olfm2 |
olfactomedin 2 |
22884 |
0.12 |
chr12_69908329_69908494 | 6.30 |
Atl1 |
atlastin GTPase 1 |
679 |
0.59 |
chrX_151168952_151169161 | 6.30 |
Gm15138 |
predicted gene 15138 |
644 |
0.61 |
chr19_48205950_48206292 | 6.26 |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
96 |
0.98 |
chr16_28445903_28447087 | 6.24 |
Fgf12 |
fibroblast growth factor 12 |
218 |
0.97 |
chr13_109926664_109927017 | 6.21 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
4 |
0.99 |
chr2_141152035_141152210 | 6.20 |
Zcchc9-ps |
zinc finger, CCHC domain containing 9, pseudogene |
24842 |
0.23 |
chr14_96518648_96518966 | 6.19 |
Klhl1 |
kelch-like 1 |
295 |
0.93 |
chr17_52601056_52601789 | 6.17 |
Gm27217 |
predicted gene 27217 |
1238 |
0.39 |
chr8_94552135_94552353 | 6.14 |
Cpne2 |
copine II |
3270 |
0.17 |
chr3_139860700_139860851 | 6.13 |
Gm43678 |
predicted gene 43678 |
48011 |
0.17 |
chr8_70120404_70120614 | 6.13 |
Ncan |
neurocan |
364 |
0.7 |
chr5_33995599_33996957 | 6.13 |
Nat8l |
N-acetyltransferase 8-like |
294 |
0.82 |
chr2_173658978_173659962 | 6.13 |
Ppp4r1l-ps |
protein phosphatase 4, regulatory subunit 1-like, pseudogene |
34 |
0.8 |
chr3_108432963_108433388 | 6.12 |
Gm22942 |
predicted gene, 22942 |
8155 |
0.09 |
chr6_127405680_127406116 | 6.11 |
Gm34091 |
predicted gene, 34091 |
5232 |
0.18 |
chr6_77243261_77243450 | 6.09 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
433 |
0.89 |
chr2_132029196_132030408 | 6.08 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
199 |
0.94 |
chr5_22095017_22095168 | 6.03 |
Reln |
reelin |
39577 |
0.17 |
chr13_78188103_78188254 | 6.00 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
2265 |
0.21 |
chr16_30023329_30023503 | 6.00 |
4632428C04Rik |
RIKEN cDNA 4632428C04 gene |
14749 |
0.14 |
chr2_146787470_146787824 | 5.97 |
Gm14111 |
predicted gene 14111 |
31942 |
0.18 |
chr13_99443818_99444236 | 5.94 |
Map1b |
microtubule-associated protein 1B |
83 |
0.97 |
chr11_8456656_8457180 | 5.94 |
Tns3 |
tensin 3 |
11757 |
0.29 |
chr8_70840798_70841569 | 5.93 |
Arrdc2 |
arrestin domain containing 2 |
1463 |
0.19 |
chr6_44408861_44409116 | 5.89 |
Gm44211 |
predicted gene, 44211 |
258447 |
0.02 |
chr5_113373212_113373489 | 5.87 |
Aym1 |
activator of yeast meiotic promoters 1 |
16056 |
0.14 |
chr9_43961435_43961779 | 5.86 |
Gm30373 |
predicted gene, 30373 |
8564 |
0.12 |
chr13_44101018_44101169 | 5.86 |
Gm33630 |
predicted gene, 33630 |
1133 |
0.49 |
chr14_35112651_35112809 | 5.85 |
Gm49034 |
predicted gene, 49034 |
106708 |
0.07 |
chr15_103135415_103135966 | 5.85 |
Gm49477 |
predicted gene, 49477 |
191 |
0.89 |
chr9_41918970_41919408 | 5.83 |
Gm40513 |
predicted gene, 40513 |
28585 |
0.14 |
chr10_76961339_76961823 | 5.82 |
Pcbp3 |
poly(rC) binding protein 3 |
207 |
0.93 |
chr3_94464755_94464906 | 5.82 |
Riiad1 |
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 |
8092 |
0.08 |
chr12_30036632_30037091 | 5.78 |
Gm15691 |
predicted gene 15691 |
22796 |
0.2 |
chr9_75625075_75626579 | 5.77 |
Lysmd2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
68 |
0.96 |
chr1_159901476_159901649 | 5.74 |
Gm38039 |
predicted gene, 38039 |
30164 |
0.18 |
chr5_116895150_116895314 | 5.73 |
Gm43122 |
predicted gene 43122 |
64678 |
0.1 |
chr4_25409420_25409571 | 5.69 |
Gm11894 |
predicted gene 11894 |
9854 |
0.22 |
chr17_23675766_23677157 | 5.68 |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
92 |
0.89 |
chr11_112869991_112870994 | 5.67 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
45313 |
0.16 |
chr7_130184084_130184252 | 5.67 |
Fgfr2 |
fibroblast growth factor receptor 2 |
1390 |
0.57 |
chr2_151967516_151967853 | 5.66 |
Mir1953 |
microRNA 1953 |
67 |
0.96 |
chr6_142964055_142964246 | 5.66 |
St8sia1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
9 |
0.97 |
chr8_86438259_86438704 | 5.63 |
Abcc12 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 12 |
96266 |
0.07 |
chr14_38321117_38321268 | 5.62 |
Gm31456 |
predicted gene, 31456 |
3288 |
0.39 |
chrX_143932561_143932819 | 5.62 |
Dcx |
doublecortin |
360 |
0.92 |
chr6_137542612_137542832 | 5.60 |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
4633 |
0.27 |
chr2_106194434_106194642 | 5.56 |
Dcdc5 |
doublecortin domain containing 5 |
27519 |
0.21 |
chr8_95703143_95704225 | 5.52 |
Ndrg4 |
N-myc downstream regulated gene 4 |
614 |
0.57 |
chr2_152068711_152068909 | 5.52 |
AA387200 |
expressed sequence AA387200 |
7998 |
0.14 |
chr12_15816204_15816428 | 5.52 |
Trib2 |
tribbles pseudokinase 2 |
469 |
0.57 |
chr8_90069471_90069806 | 5.50 |
Tox3 |
TOX high mobility group box family member 3 |
278488 |
0.01 |
chr10_81229756_81230195 | 5.49 |
Atcay |
ataxia, cerebellar, Cayman type |
810 |
0.33 |
chr17_85748614_85749073 | 5.48 |
CJ186046Rik |
Riken cDNA CJ186046 gene |
55214 |
0.11 |
chr15_102736523_102736731 | 5.47 |
Calcoco1 |
calcium binding and coiled coil domain 1 |
14449 |
0.14 |
chr17_56475522_56476833 | 5.47 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
192 |
0.93 |
chr3_136893665_136893822 | 5.47 |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isoform |
5794 |
0.22 |
chr18_68852643_68852794 | 5.46 |
Gm50260 |
predicted gene, 50260 |
47360 |
0.16 |
chr14_123065358_123065532 | 5.45 |
AA536875 |
expressed sequence AA536875 |
22163 |
0.22 |
chr5_71657445_71657639 | 5.45 |
Gabra4 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4 |
278 |
0.73 |
chr4_75213011_75213603 | 5.37 |
Dmac1 |
distal membrane arm assembly complex 1 |
64998 |
0.1 |
chr4_68953710_68954255 | 5.36 |
Brinp1 |
bone morphogenic protein/retinoic acid inducible neural specific 1 |
415 |
0.92 |
chr1_184906460_184906611 | 5.36 |
Gm38251 |
predicted gene, 38251 |
16601 |
0.16 |
chr2_168677682_168678254 | 5.35 |
Atp9a |
ATPase, class II, type 9A |
7622 |
0.21 |
chr2_33130296_33131698 | 5.32 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr5_37245988_37246869 | 5.32 |
Crmp1 |
collapsin response mediator protein 1 |
583 |
0.76 |
chr10_90966826_90966992 | 5.32 |
Apaf1 |
apoptotic peptidase activating factor 1 |
24681 |
0.17 |
chr8_70861499_70861785 | 5.31 |
Kcnn1 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 |
1365 |
0.18 |
chr15_86345165_86345316 | 5.30 |
Tbc1d22a |
TBC1 domain family, member 22a |
109735 |
0.06 |
chr4_154313039_154313190 | 5.29 |
Arhgef16 |
Rho guanine nucleotide exchange factor (GEF) 16 |
11438 |
0.15 |
chr4_9019321_9019541 | 5.29 |
Rps18-ps2 |
ribosomal protein S18, pseudogene 2 |
78172 |
0.11 |
chr1_34583668_34584368 | 5.27 |
1700101I19Rik |
RIKEN cDNA 1700101I19 gene |
4307 |
0.1 |
chr6_51056888_51057039 | 5.27 |
Gm44402 |
predicted gene, 44402 |
89695 |
0.08 |
chr1_54250036_54250196 | 5.22 |
Ccdc150 |
coiled-coil domain containing 150 |
567 |
0.6 |
chr5_136883170_136883321 | 5.21 |
Col26a1 |
collagen, type XXVI, alpha 1 |
36 |
0.96 |
chr3_18053851_18054070 | 5.19 |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
214 |
0.94 |
chr4_22487751_22488274 | 5.19 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
354 |
0.84 |
chr1_191224278_191225037 | 5.16 |
D730003I15Rik |
RIKEN cDNA D730003I15 gene |
183 |
0.92 |
chr16_29894456_29894644 | 5.16 |
Gm26569 |
predicted gene, 26569 |
51966 |
0.11 |
chr13_78200366_78200817 | 5.15 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
813 |
0.37 |
chr5_113307529_113307763 | 5.15 |
Sgsm1 |
small G protein signaling modulator 1 |
3051 |
0.16 |
chr18_60926281_60926448 | 5.15 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
585 |
0.67 |
chr7_63956761_63957700 | 5.13 |
Gm45052 |
predicted gene 45052 |
5010 |
0.15 |
chr7_139075496_139075906 | 5.12 |
Jakmip3 |
janus kinase and microtubule interacting protein 3 |
1731 |
0.34 |
chr7_44309441_44309989 | 5.12 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
538 |
0.47 |
chr18_32284110_32284261 | 5.07 |
Ercc3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 |
26916 |
0.17 |
chr2_9893444_9893603 | 5.07 |
Gata3 |
GATA binding protein 3 |
3489 |
0.14 |
chrX_73503624_73503892 | 5.06 |
Atp2b3 |
ATPase, Ca++ transporting, plasma membrane 3 |
672 |
0.61 |
chr4_140504675_140504842 | 5.06 |
Gm50453 |
predicted gene, 50453 |
58594 |
0.09 |
chr14_69855381_69855532 | 5.04 |
Pebp4 |
phosphatidylethanolamine binding protein 4 |
15036 |
0.18 |
chr1_52524360_52524511 | 5.04 |
Gm553 |
predicted gene 553 |
1533 |
0.27 |
chr5_72647648_72648602 | 5.04 |
Nipal1 |
NIPA-like domain containing 1 |
283 |
0.84 |
chr4_122831887_122832046 | 5.03 |
Ppt1 |
palmitoyl-protein thioesterase 1 |
4276 |
0.2 |
chr17_27513711_27513862 | 5.03 |
Grm4 |
glutamate receptor, metabotropic 4 |
60 |
0.94 |
chr8_85500852_85501475 | 5.03 |
Gpt2 |
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
8554 |
0.17 |
chr2_159002609_159002760 | 5.02 |
Gm44319 |
predicted gene, 44319 |
67179 |
0.12 |
chr10_85023393_85023585 | 5.02 |
Ric8b |
RIC8 guanine nucleotide exchange factor B |
14773 |
0.22 |
chr18_34089514_34089665 | 5.02 |
Gm24432 |
predicted gene, 24432 |
3856 |
0.19 |
chr7_74012764_74012935 | 5.02 |
St8sia2 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 |
825 |
0.64 |
chr7_16959904_16960115 | 5.01 |
Pnmal1 |
PNMA-like 1 |
330 |
0.77 |
chr4_43630572_43630895 | 5.01 |
Gm25262 |
predicted gene, 25262 |
692 |
0.37 |
chr6_28981268_28981880 | 4.99 |
Gm3294 |
predicted gene 3294 |
60 |
0.98 |
chr19_36001037_36001237 | 4.98 |
Htr7 |
5-hydroxytryptamine (serotonin) receptor 7 |
56203 |
0.12 |
chr4_56089046_56089235 | 4.98 |
Gm12520 |
predicted gene 12520 |
73800 |
0.11 |
chr9_36972087_36972259 | 4.97 |
Pknox2 |
Pbx/knotted 1 homeobox 2 |
15099 |
0.17 |
chr7_4119309_4120004 | 4.96 |
Ttyh1 |
tweety family member 1 |
34 |
0.91 |
chr14_55491210_55491794 | 4.95 |
Carmil3 |
capping protein regulator and myosin 1 linker 3 |
329 |
0.75 |
chr19_15803560_15803774 | 4.95 |
Gm50348 |
predicted gene, 50348 |
609 |
0.82 |
chr14_24770685_24770836 | 4.95 |
Gm47906 |
predicted gene, 47906 |
62875 |
0.12 |
chr9_101472456_101472640 | 4.95 |
Gm5161 |
predicted pseudogene 5161 |
23195 |
0.18 |
chr9_26733143_26733768 | 4.92 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
273 |
0.88 |
chr1_127575908_127576196 | 4.90 |
Tmem163 |
transmembrane protein 163 |
38622 |
0.19 |
chr12_117054555_117054730 | 4.89 |
Gm10421 |
predicted gene 10421 |
96573 |
0.08 |
chr13_83722095_83722570 | 4.89 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
951 |
0.46 |
chr2_31827981_31828159 | 4.89 |
Qrfp |
pyroglutamylated RFamide peptide |
17490 |
0.13 |
chr14_39473001_39473750 | 4.86 |
Nrg3 |
neuregulin 3 |
287 |
0.95 |
chr1_132741416_132741647 | 4.83 |
Nfasc |
neurofascin |
226 |
0.94 |
chr7_79531898_79532317 | 4.82 |
Gm35040 |
predicted gene, 35040 |
3936 |
0.11 |
chr7_48960167_48960382 | 4.82 |
Nav2 |
neuron navigator 2 |
1177 |
0.45 |
chr15_95216740_95217275 | 4.81 |
1700129L04Rik |
RIKEN cDNA 1700129L04 gene |
54613 |
0.17 |
chr7_31127074_31128340 | 4.80 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr12_17097705_17098267 | 4.79 |
Gm48538 |
predicted gene, 48538 |
32573 |
0.16 |
chrX_120290004_120290208 | 4.77 |
Pcdh11x |
protocadherin 11 X-linked |
153 |
0.96 |
chr7_44443776_44444105 | 4.77 |
Lrrc4b |
leucine rich repeat containing 4B |
1203 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 23.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
3.8 | 11.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.5 | 10.6 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.6 | 31.2 | GO:0071625 | vocalization behavior(GO:0071625) |
2.5 | 7.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.4 | 7.1 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
2.3 | 9.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.2 | 6.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.0 | 6.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.0 | 4.0 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
1.8 | 1.8 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
1.7 | 13.9 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.7 | 5.0 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.6 | 6.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.6 | 10.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.5 | 4.5 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.5 | 5.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.5 | 4.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.4 | 4.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.4 | 5.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.4 | 5.7 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.4 | 4.2 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.4 | 4.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.4 | 4.2 | GO:0060596 | mammary placode formation(GO:0060596) |
1.4 | 5.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.3 | 8.0 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.3 | 2.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.3 | 15.8 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.3 | 3.8 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.3 | 17.8 | GO:0022038 | corpus callosum development(GO:0022038) |
1.3 | 3.8 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.3 | 3.8 | GO:0061743 | motor learning(GO:0061743) |
1.2 | 12.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.2 | 3.7 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.2 | 2.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.2 | 4.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.2 | 3.5 | GO:0097503 | sialylation(GO:0097503) |
1.2 | 5.8 | GO:2001023 | regulation of response to drug(GO:2001023) |
1.1 | 3.4 | GO:0060166 | olfactory pit development(GO:0060166) |
1.1 | 5.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.1 | 4.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.1 | 3.3 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.1 | 1.1 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.1 | 1.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.1 | 2.2 | GO:1901656 | glycoside transport(GO:1901656) |
1.1 | 3.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.1 | 3.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.0 | 1.0 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
1.0 | 2.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.0 | 3.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.0 | 2.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.9 | 3.7 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.9 | 13.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.9 | 1.8 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.9 | 3.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.9 | 1.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.9 | 3.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.9 | 0.9 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.9 | 2.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.9 | 2.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.9 | 2.6 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.9 | 2.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.8 | 1.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.8 | 2.5 | GO:0032898 | neurotrophin production(GO:0032898) |
0.8 | 3.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.8 | 2.5 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.8 | 12.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.8 | 2.5 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.8 | 0.8 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.8 | 3.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.8 | 5.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.8 | 3.2 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.8 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.8 | 2.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.8 | 2.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.8 | 12.3 | GO:0035640 | exploration behavior(GO:0035640) |
0.8 | 3.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.8 | 5.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.7 | 6.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 2.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.7 | 3.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.7 | 3.6 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.7 | 2.9 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.7 | 4.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.7 | 4.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 2.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.7 | 2.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.7 | 4.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.7 | 1.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.7 | 2.8 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.7 | 2.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.7 | 1.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.7 | 1.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 1.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.7 | 0.7 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.6 | 1.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 1.9 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.6 | 3.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.6 | 1.3 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.6 | 1.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.6 | 2.5 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.6 | 1.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 3.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 1.8 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.6 | 2.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.6 | 1.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 4.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.6 | 1.8 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.6 | 3.5 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.6 | 6.4 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.6 | 1.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.6 | 6.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.6 | 1.7 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.6 | 3.9 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.6 | 1.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.6 | 1.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.6 | 1.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.6 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.6 | 2.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.5 | 2.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.5 | 29.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 3.3 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.5 | 1.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.5 | 3.8 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.5 | 0.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.5 | 2.1 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 3.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.5 | 1.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.5 | 1.6 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 2.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 1.5 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.5 | 8.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.5 | 3.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 2.5 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.5 | 5.6 | GO:0036065 | fucosylation(GO:0036065) |
0.5 | 2.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.5 | 2.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.5 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.5 | 2.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.5 | 1.0 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.5 | 7.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.5 | 1.5 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.5 | 3.9 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.5 | 3.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 4.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 1.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 1.0 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.5 | 1.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.5 | 1.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.5 | 1.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 4.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.5 | 5.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.5 | 0.9 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.5 | 6.8 | GO:0001964 | startle response(GO:0001964) |
0.5 | 0.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.5 | 2.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.5 | 1.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 1.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.4 | 1.8 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 1.8 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 3.9 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.4 | 5.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.4 | 2.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 2.2 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 0.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.4 | 1.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 1.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 3.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 1.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 1.7 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.4 | 1.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 1.7 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.4 | 1.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 0.4 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.4 | 0.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.4 | 0.4 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.4 | 0.8 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.4 | 7.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 0.8 | GO:0060013 | righting reflex(GO:0060013) |
0.4 | 0.8 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 0.8 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.4 | 2.8 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.4 | 1.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 1.2 | GO:1900094 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.4 | 1.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.4 | 1.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 0.8 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.4 | 1.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.4 | 1.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 2.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.4 | 1.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 0.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.4 | 6.1 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.4 | 2.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.4 | 1.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 1.1 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.4 | 2.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 1.5 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.4 | 1.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 1.1 | GO:0036233 | glycine import(GO:0036233) |
0.4 | 0.7 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.4 | 0.7 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 8.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 1.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.4 | 1.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.4 | 2.5 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.4 | 1.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.4 | 2.5 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 1.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.4 | 1.8 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.4 | 1.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.4 | 0.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.4 | 1.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 40.9 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.3 | 4.9 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.3 | 2.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 2.7 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 1.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 1.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.3 | 0.3 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 0.7 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 1.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 1.6 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.3 | 1.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 0.3 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 1.9 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.3 | 0.3 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.3 | 1.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 2.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 1.0 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 1.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 0.9 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.3 | 0.9 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.3 | 0.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 1.8 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.3 | 0.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 0.9 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 0.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 4.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 1.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 2.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 1.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 1.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 0.6 | GO:0060592 | mammary gland formation(GO:0060592) |
0.3 | 1.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 0.6 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 1.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 3.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 0.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 0.9 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.3 | 0.6 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.3 | 5.1 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.3 | 1.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.3 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 1.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.3 | 0.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 1.4 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.3 | 2.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 0.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 0.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 1.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 0.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 1.1 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.3 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 1.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.3 | 2.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 1.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.3 | 0.5 | GO:0046958 | nonassociative learning(GO:0046958) |
0.3 | 0.8 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.3 | 1.8 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 0.3 | GO:0086011 | membrane repolarization during action potential(GO:0086011) regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 0.8 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 0.5 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 0.5 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.3 | 0.8 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 0.5 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 0.3 | GO:0060459 | left lung development(GO:0060459) |
0.3 | 1.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 2.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.3 | 6.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.7 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 0.7 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 1.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 2.7 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.2 | 0.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 1.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 0.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 1.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.2 | 0.5 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 4.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 1.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 1.2 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 15.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 7.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.2 | 1.6 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.7 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.2 | 0.5 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.2 | 1.9 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 1.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 1.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 1.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.5 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.2 | 2.0 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.2 | 2.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.2 | 0.7 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 15.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 5.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 1.5 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 0.9 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 0.7 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.2 | 0.7 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 1.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 1.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 1.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 0.6 | GO:0015824 | proline transport(GO:0015824) |
0.2 | 1.7 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 1.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 1.5 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 1.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 2.3 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.2 | 1.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 1.0 | GO:0072044 | collecting duct development(GO:0072044) |
0.2 | 0.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 2.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 1.0 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.6 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 0.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 1.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.8 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.2 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.4 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.2 | 0.4 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.2 | 0.6 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.2 | 0.4 | GO:0090427 | activation of meiosis(GO:0090427) positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 0.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 1.0 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.2 | 0.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.6 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 1.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.6 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 4.6 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 0.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.2 | GO:0060513 | prostatic bud formation(GO:0060513) regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.2 | 0.4 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.2 | 2.6 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.2 | 0.2 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.2 | 0.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.2 | 4.2 | GO:0001508 | action potential(GO:0001508) |
0.2 | 0.2 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.2 | 0.2 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.2 | 0.9 | GO:0060004 | reflex(GO:0060004) |
0.2 | 3.9 | GO:0046677 | response to antibiotic(GO:0046677) |
0.2 | 0.4 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.7 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.2 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 5.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 1.9 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.2 | 0.3 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.2 | 2.7 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 1.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 0.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.9 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 0.5 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 0.2 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 0.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 1.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 1.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 2.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 1.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.6 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.2 | 0.5 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.2 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.4 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 0.7 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 2.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.6 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 1.0 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.6 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.8 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 4.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.7 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.4 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 1.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.4 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.4 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 1.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.3 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 1.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.4 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 1.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.6 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.4 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 1.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 1.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.7 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.8 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 8.7 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.2 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.3 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.8 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.1 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.7 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.5 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.2 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.1 | 0.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.4 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 1.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.8 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.2 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.1 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 1.0 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 0.1 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.9 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.3 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 1.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.2 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.5 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.3 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 2.8 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.7 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.3 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.1 | 0.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) polar body extrusion after meiotic divisions(GO:0040038) |
0.1 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.1 | 0.6 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.5 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 0.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.3 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 1.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.8 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.2 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.3 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.1 | 1.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 1.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.0 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.1 | 3.4 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.1 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.1 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.7 | GO:0048753 | pigment granule organization(GO:0048753) |
0.1 | 0.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.8 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 1.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.2 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.1 | 0.1 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
0.1 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.8 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.1 | GO:0072110 | glomerular mesangial cell proliferation(GO:0072110) regulation of glomerular mesangial cell proliferation(GO:0072124) |
0.1 | 0.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.2 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.2 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 1.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.1 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.1 | 0.1 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.8 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.0 | 0.0 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.5 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.0 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 1.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.2 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.0 | 0.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.0 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.0 | 0.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.0 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.0 | GO:0032058 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.0 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.0 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.0 | 0.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.1 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.3 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.5 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.3 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.0 | 0.0 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.4 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.0 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.0 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.2 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.1 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.0 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
0.0 | 0.0 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.0 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.1 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.2 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.0 | GO:0010637 | regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.0 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.0 | 0.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.1 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.1 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.1 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.0 | 0.0 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.0 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.0 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.0 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 1.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.0 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.0 | 0.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.0 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.0 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.0 | 0.0 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.7 | 1.7 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.7 | 5.2 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.6 | 8.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.4 | 17.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.3 | 5.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.2 | 21.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.0 | 20.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.0 | 3.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.0 | 10.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.0 | 3.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.0 | 12.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.0 | 2.9 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 2.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 2.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.8 | 10.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.8 | 6.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 4.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 2.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.7 | 10.2 | GO:0030673 | axolemma(GO:0030673) |
0.7 | 0.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.7 | 6.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.7 | 24.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 19.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.7 | 2.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.7 | 1.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 8.8 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 7.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 1.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 2.6 | GO:0097433 | dense body(GO:0097433) |
0.5 | 3.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.5 | 4.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 21.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.5 | 26.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 1.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 1.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 6.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.4 | 1.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 1.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 1.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 5.7 | GO:0043196 | varicosity(GO:0043196) |
0.4 | 1.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 4.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 7.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 4.5 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 1.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 2.2 | GO:0002177 | manchette(GO:0002177) |
0.4 | 1.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 1.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 2.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 1.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 2.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 0.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 3.1 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 4.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 2.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 1.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 1.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 6.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 1.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 2.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 2.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.7 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 32.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 1.1 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 3.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 1.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 1.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.4 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 1.0 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 2.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 12.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 0.8 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 2.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 16.4 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 1.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.1 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 4.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 1.0 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.2 | 10.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 0.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 3.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 16.1 | GO:0098794 | postsynapse(GO:0098794) |
0.1 | 0.1 | GO:0044298 | cell body membrane(GO:0044298) |
0.1 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 1.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 2.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 16.1 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 1.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.0 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 21.8 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 0.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 1.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 3.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.0 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 7.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.4 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.9 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 2.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.4 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.0 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.0 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.0 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.0 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.1 | 15.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.9 | 8.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.5 | 7.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.3 | 9.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
2.1 | 6.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.8 | 5.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.7 | 5.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.7 | 5.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.5 | 7.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.5 | 8.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.4 | 7.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.4 | 8.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.4 | 7.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.4 | 5.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.3 | 4.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.3 | 6.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.2 | 3.6 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.1 | 14.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.1 | 5.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.1 | 21.1 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.0 | 3.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.0 | 2.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.0 | 22.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.0 | 2.9 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.9 | 4.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 3.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.9 | 2.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.9 | 2.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.9 | 2.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.8 | 6.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.8 | 3.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 25.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.8 | 2.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.8 | 4.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.8 | 2.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.8 | 5.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.8 | 2.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.7 | 2.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 2.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.7 | 2.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.7 | 2.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.7 | 8.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.7 | 2.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.7 | 2.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 3.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 1.3 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.6 | 1.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.6 | 1.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.6 | 3.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.6 | 2.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.6 | 2.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.6 | 4.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 1.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.6 | 1.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 5.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 2.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.5 | 1.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 1.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.5 | 14.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 1.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.5 | 7.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.5 | 3.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.5 | 1.0 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.5 | 7.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 3.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 2.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 0.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 1.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 6.3 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 0.9 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.4 | 1.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 0.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 9.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 2.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 1.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 1.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 1.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 4.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 4.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 6.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 1.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 1.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 1.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 2.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 1.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 2.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.4 | 1.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 8.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 7.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 2.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 1.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 1.5 | GO:0038100 | nodal binding(GO:0038100) |
0.4 | 1.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.4 | 2.9 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.4 | 1.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 0.4 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.4 | 1.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 1.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 2.8 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.4 | 2.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 3.5 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.3 | 3.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 11.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.3 | 1.6 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.3 | 2.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 0.3 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.3 | 1.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.3 | 0.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 0.6 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 0.9 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 1.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 4.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 7.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.3 | 2.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 4.5 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 1.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 1.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 4.0 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 0.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 5.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.3 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 2.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.7 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.3 | 0.8 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 0.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 3.3 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 1.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 3.5 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 4.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 1.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 1.8 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.3 | 1.6 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.3 | 0.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 2.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 3.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.5 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 1.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 0.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 1.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 6.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 10.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 2.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 5.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.9 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 1.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 1.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 3.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 1.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 1.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 2.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.8 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 1.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 1.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 1.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 1.9 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 5.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 2.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 0.9 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.2 | 2.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 3.4 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 2.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 2.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.5 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 1.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.2 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 3.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 4.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 4.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 0.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 0.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 1.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 3.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.3 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 1.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 2.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 2.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 4.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 10.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.7 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 3.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 2.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 3.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 2.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 4.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 2.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 2.0 | GO:0052634 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 1.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.4 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.5 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 1.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 1.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 3.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 5.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.2 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.3 | GO:0018501 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 1.2 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.3 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.1 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.3 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.3 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 1.2 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.0 | 0.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 2.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 3.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0018639 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.0 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.1 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 1.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 1.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.0 | GO:0032557 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) pyrimidine ribonucleotide binding(GO:0032557) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.5 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 13.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.7 | 2.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.6 | 15.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 1.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 9.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 0.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 6.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 3.0 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 1.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 4.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 3.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 12.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 7.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 3.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 1.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 1.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 1.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 3.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 2.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 5.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 3.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 5.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 2.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 9.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 2.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 8.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 20.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.1 | 1.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.1 | 12.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.0 | 14.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 9.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.9 | 40.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.8 | 4.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.7 | 7.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 13.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 7.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.7 | 9.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 9.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 9.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.6 | 2.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.5 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 8.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 8.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 5.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 6.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 4.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 4.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.4 | 3.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 4.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 4.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 0.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.3 | 3.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 6.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 3.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 3.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 4.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 2.0 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.3 | 5.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 3.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 0.5 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.3 | 2.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 2.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 8.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 2.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 5.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 9.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.2 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.2 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 3.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 3.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 0.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 1.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 2.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 3.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 3.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 4.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 0.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.2 | 1.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 2.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 5.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 9.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 3.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 3.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 1.0 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.1 | 0.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.0 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 1.0 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 1.3 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 2.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 1.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.4 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.1 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 4.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.1 | REACTOME IMMUNE SYSTEM | Genes involved in Immune System |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.0 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |